药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Brodalumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Brodalumab.
Tazarotene
Sarilumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Sarilumab.
Tazarotene
Peficitinib
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Peficitinib.
Tazarotene
Voclosporin
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Voclosporin.
Tazarotene
Pirarubicin
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Pirarubicin.
Tazarotene
Ravulizumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Ravulizumab.
Tazarotene
Ixekizumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Ixekizumab.
Tazarotene
Melengestrol
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Melengestrol.
Tazarotene
Dexamethasone isonicotinate
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Dexamethasone isonicotinate.
Tazarotene
Tepoxalin
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Tepoxalin.
Tazarotene
Meprednisone
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Meprednisone.
Tazarotene
Fluprednisolone
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Fluprednisolone.
Tazarotene
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Antilymphocyte immunoglobulin (horse).
Tazarotene
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Peginterferon beta-1a.
Tazarotene
Tixocortol
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Tixocortol.
Tazarotene
Vilanterol
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Vilanterol.
Tazarotene
Dinutuximab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Dinutuximab.
Tazarotene
Olaparib
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Olaparib.
Tazarotene
Palbociclib
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Palbociclib.
Tazarotene
Idelalisib
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Idelalisib.